Martingale Asset Management L P Crinetics Pharmaceuticals, Inc. Transaction History

Martingale Asset Management L P

  • $4.56 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$15.97 - $30.59 $60,733 - $116,333
-3,803 Reduced 7.89%
44,377 $1.32 Million
Q1 2023

May 12, 2023
BUY
$15.31 - $21.1 $38,275 - $52,750
2,500 Added 5.47%
48,180 $773,000
Q4 2022

Feb 13, 2023
BUY
$15.49 - $19.05 $707,583 - $870,204
45,680 New
45,680 $835,000

Others Institutions Holding CRNX

# of Institutions
244
Shares Held
78.2M
Call Options Held
268K
Put Options Held
197K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.73B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email